Pfizer’s First Gene Therapy Approval Sets Up a Showdown With CSL in Hemophilia B
Pfizer’s first FDA-approved gene therapy is the second such treatment for the inherited bleeding disorder hemophilia B, introducing some competition to a therapeutic area that now has two of the most expensive medicines in the world. The FDA approval …